https://www.selleckchem.com/pr....oducts/Camptothecine
One patient required conversion to surgical aortic valve replacement. The success rate was 99 percent. The outcomes were all-cause mortality 0.9%, stroke rate 1.9%, New pacemaker rate 5.7%, 87.6% had no paravalvular leak. The mild and moderate paravalvular leak was seen in 2.8% and 1.9%, respectively. The mean gradient decreased from 47.5mmHg to 9mmHg. The average ICU stay was 26.4h, and the average hospital stay was 5.4 days. Our outcomes are comparable with the latest published low-risk trial. Minimalist, conscious sedation, tra